Guided Therapeutics Prix / Ventes
Quel est le Prix / Ventes de Guided Therapeutics?
Le Prix / Ventes de Guided Therapeutics, Inc. est 111.26
Quelle est la définition de Prix / Ventes?
Le rapport prix / ventes est le prix des actions d'une entreprise par rapport à ses revenus.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Prix / Ventes des entreprises dans Health Care secteur sur OTC par rapport à Guided Therapeutics
Que fait Guided Therapeutics?
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Entreprises avec prix / ventes similaire à Guided Therapeutics
- Hansa Trust A Shares a Prix / Ventes de 110.56
- Gadsden Properties a Prix / Ventes de 110.77
- Gadsden Properties a Prix / Ventes de 110.77
- iShares Trust - iShares Russell 2000 ETF a Prix / Ventes de 110.94
- Fairfax India a Prix / Ventes de 111.02
- BlackRock Maryland Municipal Bond Trust a Prix / Ventes de 111.21
- Guided Therapeutics a Prix / Ventes de 111.26
- Repro India a Prix / Ventes de 111.79
- Hansa Trust Plc a Prix / Ventes de 111.96
- ASA Gold and Precious Metals Ltd a Prix / Ventes de 112.21
- Sanwaria Consumer a Prix / Ventes de 112.41
- BlackRock MuniVest Fund a Prix / Ventes de 113.31
- Wilmington Capital Management a Prix / Ventes de 114.06